rs10918215

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_007348.4(ATF6):​c.1804+17561G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.631 in 152,030 control chromosomes in the GnomAD database, including 32,015 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 32015 hom., cov: 31)

Consequence

ATF6
NM_007348.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0160

Publications

7 publications found
Variant links:
Genes affected
ATF6 (HGNC:791): (activating transcription factor 6) This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
ATF6 Gene-Disease associations (from GenCC):
  • achromatopsia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • ATF6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • achromatopsia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.746 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATF6NM_007348.4 linkc.1804+17561G>A intron_variant Intron 15 of 15 ENST00000367942.4 NP_031374.2 P18850A8K383
ATF6NM_001437597.1 linkc.1861+17561G>A intron_variant Intron 15 of 15 NP_001424526.1
ATF6NM_001410890.1 linkc.1801+17561G>A intron_variant Intron 15 of 15 NP_001397819.1
ATF6XM_011509309.1 linkc.1858+17561G>A intron_variant Intron 15 of 15 XP_011507611.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATF6ENST00000367942.4 linkc.1804+17561G>A intron_variant Intron 15 of 15 1 NM_007348.4 ENSP00000356919.3 P18850

Frequencies

GnomAD3 genomes
AF:
0.631
AC:
95828
AN:
151912
Hom.:
31999
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.433
Gnomad AMI
AF:
0.666
Gnomad AMR
AF:
0.534
Gnomad ASJ
AF:
0.723
Gnomad EAS
AF:
0.520
Gnomad SAS
AF:
0.593
Gnomad FIN
AF:
0.806
Gnomad MID
AF:
0.696
Gnomad NFE
AF:
0.751
Gnomad OTH
AF:
0.643
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.631
AC:
95873
AN:
152030
Hom.:
32015
Cov.:
31
AF XY:
0.628
AC XY:
46685
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.433
AC:
17953
AN:
41452
American (AMR)
AF:
0.533
AC:
8142
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.723
AC:
2509
AN:
3472
East Asian (EAS)
AF:
0.520
AC:
2683
AN:
5160
South Asian (SAS)
AF:
0.594
AC:
2859
AN:
4810
European-Finnish (FIN)
AF:
0.806
AC:
8514
AN:
10562
Middle Eastern (MID)
AF:
0.701
AC:
206
AN:
294
European-Non Finnish (NFE)
AF:
0.751
AC:
51051
AN:
67978
Other (OTH)
AF:
0.638
AC:
1349
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1655
3310
4964
6619
8274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
770
1540
2310
3080
3850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.649
Hom.:
5464
Bravo
AF:
0.602
Asia WGS
AF:
0.521
AC:
1814
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.4
DANN
Benign
0.44
PhyloP100
-0.016
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10918215; hg19: chr1-161899731; API